Skip to main content
Signal8

CYduct Diagnostics, Inc. (CYDX)

CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.

Industry: Medical - Devices

CYduct Diagnostics, Inc. logo

CYduct Diagnostics, Inc.

OTC:CYDXHealthcare
Mkt Cap$2.4M
Float5.05M
O/S-
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$70K
Net Income-$207K
Total Assets$30K
Free Cash Flow$12K
Debt & Equity
Total Debt$708K
Total Equity-$1.06M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in CYDX's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$30K
Liabilities$1.09M
Accounts Receivable$12K
Accounts Payable$255K
Inventory$10K
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue$70K$71K$84K$119K$94K$161K$194K$184K$232K$263K$266K
YoY Growth-0.4%-16.3%-29.2%26.9%-41.5%-17.3%5.5%-20.6%-11.6%-1.4%-
Cost of Revenue$27K$24K$28K$36K$31K$45K$63K$92K$97K$110K$110K
Gross Profit$44K$47K$57K$83K$64K$116K$132K$93K$135K$153K$156K
Gross Margin62.3%66.2%67.0%69.9%67.5%71.8%67.7%50.3%58.1%58.1%58.6%
Research and Development$0$0$0$0$0$0$0$0$0$0$0
Selling, General, and Administrative$199K$410K$436K$525K$467K$486K$380K$379K$321K$471K$488K
Other$0$0$0$0$0$0$0$0$0$0$0
Total Operating Expenses$199K$410K$436K$525K$467K$486K$380K$379K$321K$471K$488K
Operating Income (EBIT)-$155K-$363K-$379K-$445K-$404K-$371K-$249K-$287K-$186K-$318K-$332K
Operating Margin-220.1%-513.8%-448.5%-372.6%-429.1%-230.6%-128.0%-155.4%-80.0%-121.3%-124.7%
Interest Expense$53K$50K$39K$31K$17K$1K$2K$0$906$2K$2K
Interest Income$0$0$0$0$0$0$0$0$0$0$0
Other Income (Expense)-$53K-$50K-$39K-$31K-$17K-$1K$808K$2.2M-$432K-$1.16M-$3.32M
Income Before Tax (EBT)-$207K-$414K-$418K-$476K-$420K-$372K$559K$1.92M-$617K-$1.48M-$3.65M
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0
Net Income-$207K-$414K-$418K-$473K-$420K-$372K$559K$1.92M-$617K-$1.48M-$3.65M
Net Income Margin-294.7%-585.1%-494.8%-396.1%-447.1%-231.3%287.5%1039.3%-265.9%-562.6%-1370.2%
Supplementary Data
EPS-0.04-0.08-0.08-0.09-0.08-0.070.193.14-1.31-5.32-18.30
Diluted EPS-0.04-0.08-0.08-0.09-0.08-0.070.193.14-1.31-5.32-18.30
Weighted Average OS5.55M5.24M5.20M5.14M5.14M5.00M2.94M610,002472,055277,908199,110
EBITDA-$155K-$363K-$379K-$441K-$167K-$371K$732K$1.92M-$617K-$1.48M-$332K
EBITDA Margin-220.1%-513.8%-448.5%-369.7%-177.5%-230.6%376.7%1039.3%-265.5%-561.9%-124.7%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302019-12-312018-12-312017-12-312016-12-312015-12-31
Assets
Current Assets
Cash and Cash Equivalents$7K$1K$30K$55K$272K$19K$18K$31K$10K$2K$13K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$7K$1K$30K$55K$272K$19K$18K$31K$10K$2K$13K
Accounts Receivable$12K$19K$13K$12K$8K$29K$14K$22K$52K$53K$13K
Inventory$10K$18K$12K$14K$17K$24K$20K$24K$44K$106K$144K
Other Current Assets$0$0$0$0$0$0$0$0$0$0$0
Total Current Assets$30K$38K$55K$81K$297K$71K$52K$76K$105K$162K$169K
Long-Term Assets
Property, Plant & Equipment Net$0$0$0$0$0$0$0$0$0$0$0
Goodwill$0$0$0$0$0$0$0$0$0$900K$900K
Intangible Assets$0$0$0$0$0$0$50K$50K$50K$1.05M$1.05M
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$0$0$0$0$0$0$0$0$0-$900K-$900K
Total Long-Term Assets$0$0$0$0$0$0$50K$50K$50K$1.05M$1.05M
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$30K$38K$55K$81K$297K$71K$102K$126K$155K$1.21M$1.22M
Liabilities
Current Liabilities
Accounts Payable$255K$211K$117K$70K$1.33M$1.06M$775K$552K$314K$616K$477K
Short-Term Debt$80K$85K$80K$280K$80K$80K$80K$40K$0$25K$26K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$1.61M$0$0$0$0$0$0$0$0
Other Current Liabilities$123K$87K$58K$1.46M$0$0$0$809K$3.02M$3.28M$2.17M
Total Current Liabilities$457K$2.22M$1.86M$1.81M$1.41M$1.14M$855K$1.4M$3.34M$3.92M$2.67M
Long-Term Liabilities
Long-Term Debt$628K$628K$590K$290K$440K$60K$0$40K$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$628K$628K$590K$290K$440K$60K$0$40K$0$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$1.09M$2.85M$2.45M$2.1M$1.85M$1.2M$855K$1.44M$3.34M$3.92M$2.67M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$506$755$796$605
Common Stock$13K$5K$5K$5K$5K$5K$1.25M$205K$135K$86K$57K
Retained Earnings-$14.76M-$14.55M-$14.14M-$13.72M-$13.24M-$12.82M-$12.38M-$12.94M-$14.86M-$14.24M-$12.76M
Comprehensive Income & Other$0$0$0$11.69M$11.69M$11.69M$11.63M$11.63M$11.68M$11.53M$11.31M
Other Stockholders' Equity$13.69M$11.74M$11.74M$11.69M$11.69M$11.69M$10.38M$11.43M$11.54M$11.45M$11.25M
Total Equity-$1.06M-$2.81M-$2.4M-$2.02M-$1.55M-$1.13M-$753K-$1.31M-$3.18M-$2.71M-$1.45M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$30K$38K$55K$81K$297K$71K$102K$129K$155K$1.21M$1.22M
Supplementary Data
Total Debt$708K$713K$670K$570K$520K$140K$80K$80K$0$25K$26K
Net Debt$701K$712K$640K$515K$248K$121K$62K$49K-$10K$24K$13K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302019-12-312018-12-312017-12-312016-12-312015-12-31
Operating Activities
Net Income-$207K-$414K-$418K-$473K-$420K-$372K$559K$1.92M-$617K-$1.48M-$3.65M
Depreciation & Amortization$0$0$0$0$0$0$0$0$0$0$0
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable$6K-$6K-$1K-$4K$21K-$18K$11K$28K$5K-$41K$30K
  Inventory$7K-$6K$2K$2K$7K-$12K$4K$19K$63K$37K$29K
  Accounts Payable$44K$94K$242K$24K$265K$282K$223K$228K$169K$140K$189K
  Other Working Capital$161K$259K$0$184K-$680$0$0$0$0$0$0
Total Working Capital Change$219K$342K$243K$206K$293K$253K$238K$275K$236K$136K$248K
Other Non-Cash Items$0$0$0$0$0$62K-$809K-$2.48M$153K$1.15M$3.16M
Net Cash from Operating$11K-$72K-$175K-$267K-$128K-$58K-$12K-$12K$8K-$59K$8K
Investing Activities
Capital Expenditures$0$0$3$4$0$0$0$0$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities$0$0-$194-$4$0$0$0$0$0$0$0
Net Cash from Investing$0$0-$191$0$0$0$0$0$0$0$0
Financing Activities
Debt Repaid$5K-$43K-$100K-$50K-$381K------
Common Stock Issuance$0$0$50K$0$0$0$0$0$0$48K$2K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$0$0$0$0$0$0$32K$0$0$2K
Net Cash from Financing-$5K$43K$150K$50K$381K$0$0$32K$0$48K$2K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$6K-$29K-$25K-$217K$253K$553-$12K$21K$8K-$11K$10K
Supplementary Data
Operating Cash Flow$11K-$72K-$175K-$267K-$128K-$58K-$12K-$12K$8K-$59K$8K
Capital Expenditure$5$0$3$4$3$0$0$0$0$0$0
Free Cash Flow$12K-$72K-$175K-$267K-$128K-$58K-$12K-$12K$8K-$59K$8K
Cash at Beginning$1K$30K$55K$272K$19K$18K$31K$10K$2K$13K$3K
Cash at End$7K$1K$30K$55K$272K$19K$18K$31K$10K$2K$13K